10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELI LILLY & CO | |||
Ticker: LLY Fiscal Year: 2016 | |||
Consolidated Statements of Operations | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 21, 2017) | |||
| (In Thousands) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Revenue | $ 21,222,100 | 19,958,700 | 19,615,600 |
| Costs, expenses, and other: | |||
| Cost of sales | 5,654,900 | 5,037,200 | 4,932,500 |
| Research and development | 5,243,900 | 4,796,400 | 4,733,600 |
| Marketing, selling, and administrative | 6,452,000 | 6,533,000 | 6,620,800 |
| Acquired in-process research and development | 30,000 | 535,000 | 200,200 |
| Asset impairment, restructuring, and other special charges | 382,500 | 367,700 | 468,700 |
| Other-net, (income) expense | 84,800 | (100,600) | (340,500) |
| Cost of sales, operating expenses, and other-net | 17,848,100 | 17,168,700 | 16,615,300 |
| Income before income taxes | 3,374,000 | 2,790,000 | 3,000,300 |
| Income taxes | 636,400 | 381,600 | 609,800 |
| Net income | 2,737,600 | 2,408,400 | 2,390,500 |
| Earnings per share: | |||
| Basic | 2.59 | 2.27 | 2.23 |
| Diluted | 2.58 | 2.26 | 2.23 |
| Shares used in calculation of earnings per share: | |||
| Basic | 1,058,324 | 1,061,913 | 1,069,932 |
| Diluted | 1,061,825 | 1,065,720 | 1,074,286 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELI LILLY & CO | |||
Ticker: LLY Fiscal Year: 2016 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 21, 2017) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Net income | $ 2,737,600 | 2,408,400 | 2,390,500 |
| Other comprehensive income (loss): | |||
| Change in foreign currency translation gains (losses) | (436,400) | (859,800) | (961,400) |
| Change in net unrealized gains and losses on securities | 303,000 | (138,100) | (162,200) |
| Change in defined benefit pension and retiree health benefit plans | (512,800) | 572,900 | (1,327,600) |
| Change in effective portion of cash flow hedges | 11,700 | (42,000) | (14,500) |
| Other comprehensive income (loss) before income taxes | (634,500) | (467,000) | (2,465,700) |
| Provision for income taxes related to other comprehensive income (loss) items | (10,600) | (121,900) | 476,600 |
| Other comprehensive income (loss), net of tax | (645,100) [1] | (588,900) | (1,989,100) |
| Comprehensive income | 2,092,500 | 1,819,500 | 401,400 |
| Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | (693,300) | ||
| Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest | 48,200 | ||
| [1] Other comprehensive loss in 2016 consists of $693.3 million of other comprehensive loss attributable to controlling interest and $48.2 million of other comprehensive income attributable to non-controlling interest. | |||
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELI LILLY & CO | |||
Ticker: LLY Fiscal Year: 2016 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 21, 2017) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Cash and Cash Equivalents, Period Increase (Decrease) [Abstract] | |||
| Net Cash Provided by Operating Activities [Abstract] | |||
| Cash Flows from Operating Activities | |||
| Net income | $ 2,737,600 | 2,408,400 | 2,390,500 |
| Adjustments to Reconcile Net Income to Cash Flows from Operating Activities: | |||
| Depreciation and amortization | 1,496,600 | 1,427,700 | 1,379,000 |
| Change in deferred income taxes | 439,500 | (748,400) | 36,800 |
| Stock-based compensation expense | 255,300 | 217,800 | 156,000 |
| Acquired in-process research and development | 30,000 | 535,000 | 200,200 |
| Net proceeds from (payments for) terminations of interest rate swaps | (3,400) | (186,100) | 340,700 |
| Other non-cash operating activities, net | 379,500 | 449,400 | 280,700 |
| Other changes in operating assets and liabilities, net of acquisitions and divestitures: | |||
| Receivables - (increase) decrease | (709,400) | (304,500) | 117,400 |
| Inventories - (increase) decrease | (328,200) | (736,300) | (307,100) |
| Other assets - (increase) decrease | (265,500) | (288,500) | 673,200 |
| Accounts payable and other liabilties-increase (decrease) | 819,000 | 190,100 | (809,000) |
| Net Cash Provided by Operating Activities | 4,851,000 | 2,964,600 | 4,458,400 |
| Net Cash Provided By (Used In) Investing Activities [Abstract] | |||
| Cash Flows from Investing Activities | |||
| Purchases of property and equipment | (1,037,000) | (1,066,200) | (1,162,600) |
| Disposals of property and equipment | 73,400 | 92,600 | 15,300 |
| Cash released (restricted) for pending acquisition | 0 | 5,405,600 | (5,405,600) |
| Proceeds from sales and maturities of short-term investments | 1,642,000 | 2,161,800 | 4,054,100 |
| Purchases of short-term investments | (1,327,400) | (842,200) | (1,637,800) |
| Proceeds from sales of noncurrent investments | 2,086,000 | 3,068,400 | 11,009,400 |
| Purchases of noncurrent investments | (4,346,000) | (3,226,500) | (9,802,700) |
| Proceeds from sale of product rights | 0 | 410,000 | 0 |
| Purchase of product rights | 0 | 0 | (308,300) |
| Purchases of in-process research and development | (55,000) | (560,000) | (95,000) |
| Cash paid for acquisitions, net of cash acquired | (45,000) | (5,283,100) | (551,400) |
| Other investing activities, net | (130,100) | (133,600) | (24,500) |
| Net Cash Provided by (Used for) Investing Activities | (3,139,100) | 26,800 | (3,909,100) |
| Net Cash Used in Financing Activities [Abstract] | |||
| Cash Flows from Financing Activities | |||
| Dividends paid | (2,158,500) | (2,127,300) | (2,101,200) |
| Net change in short-term borrowings | 1,293,200 | (2,680,600) | 2,680,600 |
| Proceeds from issuance of long-term debt | 1,206,600 | 4,454,700 | 992,900 |
| Repayments of long-term debt | (200) | (1,955,700) | (1,034,800) |
| Purchases of common stock | (600,100) | (749,500) | (800,000) |
| Other financing activities, net | (300,800) | (52,600) | 96,100 |
| Net Cash Used for Financing Activities | (559,800) | (3,111,000) | (166,400) |
| Effect of exchange rate changes on cash and cash equivalents | (236,400) | (85,600) | (341,500) |
| Net increase (decrease) in cash and cash equivalents | 915,700 | (205,200) | 41,400 |
| Cash and cash equivalents at beginning of year | 3,666,400 | 3,871,600 | |
| Cash and Cash Equivalents at End of Year | 4,582,100 | 3,666,400 | 3,871,600 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ELI LILLY & CO | ||
Ticker: LLY Fiscal Year: 2016 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2016 10-K (Filed: Feb 21, 2017) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2016 | Dec 31, 2015 | |
| Assets Abstract | ||
| Current Assets | ||
| Cash and cash equivalents | $ 4,582,100 | 3,666,400 |
| Short-term investments | 1,456,500 | 785,400 |
| Accounts receivable, net of allowances of $40.3 (2016) and $44.3 (2015) | 4,029,400 | 3,513,000 |
| Other receivables | 736,900 | 558,600 |
| Inventories | 3,561,900 | 3,445,800 |
| Prepaid expenses and other | 734,600 | 604,400 |
| Total current assets | 15,101,400 | 12,573,600 |
| Other Assets | ||
| Investments | 5,207,500 | 3,646,600 |
| Goodwill | 3,972,700 | 4,039,900 |
| Other intangibles, net | 4,357,900 | 5,034,800 |
| Sundry | 1,913,800 | 2,220,500 |
| Total other assets | 15,451,900 | 14,941,800 |
| Property and equipment, net | 8,252,600 | 8,053,500 |
| Total assets | 38,805,900 | 35,568,900 |
| Liabilities and Shareholders' Equity | ||
| Current Liabilities | ||
| Short-term borrowings and current maturities of long-term debt | 1,937,400 | 6,100 |
| Accounts payable | 1,349,300 | 1,338,200 |
| Employee compensation | 896,900 | 967,000 |
| Sales rebates and discounts | 3,914,900 | 2,560,100 |
| Dividends payable | 548,100 | 539,000 |
| Income taxes payable | 119,100 | 358,900 |
| Other current liabilities | 2,220,900 | 2,460,300 |
| Total current liabilities | 10,986,600 | 8,229,600 |
| Other Liabilities | ||
| Long-term debt | 8,367,800 | 7,972,400 |
| Accrued retirement benefits | 2,453,900 | 2,160,300 |
| Long-term income taxes payable | 688,900 | 868,900 |
| Other noncurrent liabilities | 2,228,200 | 1,747,400 |
| Total other liabilities | 13,738,800 | 12,749,000 |
| Eli Lilly and Company Shareholders' Equity | ||
| Common stock-no par value Authorized shares: 3,200,000 Issued shares: 1,101,586 (2016) and 1,106,063 (2015) | 688,500 | 691,300 |
| Additional paid-in capital | 5,640,600 | 5,552,100 |
| Retained earnings | 16,046,300 | 16,011,800 |
| Employee benefit trust | (3,013,200) | (3,013,200) |
| Accumulated other comprehensive loss | (5,274,000) | (4,580,700) |
| Cost of common stock in treasury | (80,500) | (90,000) |
| Total Eli Lilly and Company shareholders' equity | 14,007,700 | 14,571,300 |
| Noncontrolling interests | 72,800 | 19,000 |
| Total equity | 14,080,500 | 14,590,300 |
| Total liabilities and equity | 38,805,900 | 35,568,900 |
| External Links | |
| ELI LILLY & CO (LLY) Fiscal Year 2016 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |